Overcome challenges in cancer research with IDT’s xGen™ NGS solutions for oncology and MRD research
ฝัง
- เผยแพร่เมื่อ 22 ก.ย. 2024
- In this video, we’ve outlined the many ways in which your research will benefit from IDT’s xGen NGS solutions for cancer research, including highlights on:
• High library complexity from low quality samples
• Predesigned and custom approaches for hybridization capture
• Complete sample preparation workflow for Minimal residual disease (MRD) research
Learn more at idtb.io/38dtmd